세계의 원형 탈모증 시장 보고서(2025년)

Alopecia areata, commonly known as spot baldness, is an autoimmune disorder in which the immune system mistakenly targets hair follicles, leading to hair loss and the formation of patchy bald spots on the scalp, each resembling the size of a coin. This non-scarring condition can occur at any age and is characterized by the sudden onset of hair loss, resulting in small, soft, and hairless patches.

The primary types of alopecia areata include patchy alopecia areata, alopecia totalis, alopecia universalis, diffuse alopecia areata, ophiasis alopecia, and others. Patchy alopecia areata manifests as small circular patches of hair loss on the scalp or other areas of the body. Various treatments are available, encompassing medical and natural approaches. Diagnosis can be achieved through techniques such as trichoscopy, skin biopsy, and other diagnostic methods. Treatments may be administered through various routes, including oral, topical, parenteral, among others, and are utilized by diverse end-users, including hospitals, specialty clinics, homecare, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The alopecia areata market research report is one of a series of new reports from The Business Research Company that provides alopecia areata market statistics, including alopecia areata industry global market size, regional shares, competitors with a alopecia areata market share, detailed alopecia areata market segments, market trends and opportunities, and any further data you may need to thrive in the alopecia areata industry. This alopecia areata market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alopecia areata market size has grown strongly in recent years. It will grow from $3.58 billion in 2024 to $3.81 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to limited treatment options, advancements in immunology, increased disease awareness, clinical trials and drug development, psychosocial impact awareness.

The alopecia areata market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to biologic therapies development, precision medicine approaches, advancements in immunotherapy, ai and drug discovery, global initiatives and funding. Major trends in the forecast period include topical immunotherapy advancements, combination therapies, telemedicine in dermatology, patient-centric care, regulatory pathways for novel therapies.

The forecast of 8.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of topical immunotherapy solutions and platelet-rich plasma kits sourced from South Korea and Sweden, thereby reducing treatment efficacy and elevating dermatology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The prevalence of hair loss is anticipated to be a driving force behind the expansion of the alopecia areata market. Hair loss occurs due to disruptions in the body's natural hair growth cycle. Treatment for alopecia areata involves the use of corticosteroids, potent anti-inflammatory medications that can suppress the immune system, to address the condition wherein the immune system attacks hair follicles, leading to hair loss. For instance, as reported by the Hair Society in March 2022, approximately 21 million women and 35 million men globally experienced hair loss. Hair loss typically begins around age 35, affecting the majority of individuals, with a 40% hair loss rate for males, escalating to 70% by age 80. Women, experiencing hair loss, comprise 80% or more by the age of 60. Hence, the escalating prevalence of hair loss is steering the growth of the alopecia areata market.

The increased occurrence of alopecia stands poised to fuel the expansion of the alopecia areata market. Alopecia encompasses the partial or complete loss of hair, predominantly from the scalp but potentially affecting other body areas. Alopecia can manifest in various forms, from mild, temporary hair thinning to severe and permanent hair loss. For instance, as indicated by an article published by the U.S. Department of Health and Human Services in July 2023, more than 50 million men and 30 million women are estimated to grapple with androgenetic alopecia in the U.S. annually. Consequently, the rising incidence of alopecia is propelling the growth trajectory of the alopecia areata market.

The approval of innovative drugs stands out as a significant trend gaining momentum. Major industry players are actively pursuing new drug approvals to fortify their market presence and secure a competitive edge. For instance, in June 2023, Pfizer Inc., a US-based biotechnology and pharmaceutical company, unveiled the US Food and Drug Administration (FDA) approval for LITFULO (ritlecitinib), marking the first and sole treatment approved for severe alopecia areata in patients as young as 12. This oral treatment, administered once daily, addresses alopecia areata, an autoimmune condition previously lacking FDA-endorsed treatments for teenagers and offering limited options for adults. LITFULO operates as a kinase inhibitor, targeting Janus kinase 3 (JAK3) and the tyrosine kinase family of kinases found in hepatocellular carcinoma (TEC).

Strategic partnerships represent another prominent trend gaining traction within the alopecia areata market. Leading companies in this sector are actively forging alliances to fortify their market standings. For instance, in February 2023, UMass Chan Medical School, a US-based public medical school, licensed a siRNA technology for dermatological diseases developed by RNA therapeutics to Aldena Therapeutics for clinical development. These siRNA-based therapeutics hold promise in addressing various skin conditions, including alopecia areata, atopic dermatitis, and vitiligo through localized treatments such as intradermal injection or topical, transepidermal applications. The agreement stems from an ongoing sponsored research agreement between the institutions, aiming to develop siRNA constructs targeting a wide array of molecular targets for diverse dermatological indications. Aldena Therapeutics, a Switzerland-based biotech firm, aims to deliver advanced, long-lasting treatments for dermatological diseases.

In March 2023, Sun Pharmaceutical Industries Limited, a prominent pharmaceutical company based in India, successfully acquired Concert Pharmaceuticals for a total of $576 million. This strategic acquisition is aimed at expanding Sun Pharma's presence within the Boston biotech cluster. Additionally, the acquisition includes deuruxolitinib, a late-stage therapeutic candidate with the potential to be a best-in-class treatment for alopecia areata, thereby enhancing Sun Pharma's growing global dermatology portfolio. Concert Pharmaceuticals, the acquired company, is a US-based late-stage clinical biopharmaceutical firm specializing in the development of products for the treatment of alopecia areata.

Major companies operating in the alopecia areata market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., GlaxoSmithKline plc., Eli Lilly and Co Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Incyte Corporation, Dr. Reddy's Laboratories Ltd., Cipla Ltd., Taisho Pharmaceutical Holdings Co. Ltd., Lupin Ltd., Glenmark Pharmaceuticals Ltd., Almirall S.A., Torrent Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Aclaris Therapeutics Inc., BioSplice Therapeutics Inc., PureTech Health plc, HCell Inc., Histogen Inc.

North America was the largest region in the alopecia areata market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia areata market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the alopecia areata market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The alopecia areata market consists of revenues earned by entities by providing combination therapy, topical immunotherapy, photochemotherapy, and aromatherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia areata market also includes sales of glucocorticoids, vasodilators, immunomodulators, and Janus kinase inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alopecia Areata Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alopecia areata market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alopecia areata ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The alopecia areata market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Patchy Alopecia Areata; Alopecia Totalis; Alopecia Universalis; Diffuse Alopecia Areata; Ophiasis Alopecia; Other Types
• 2) By Treatment: Medical Treatments; Natural Treatment; Other Treatments
• 3) By Diagnosis: Trichoscopy; Skin Biopsy; Other Diagnoses
• 4) By Route Of Administration: Oral; Topical; Parenteral; Other Routes Of Administration
• 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Patchy Alopecia Areata: Single Patch; Multiple Patches
• 2) By Alopecia Totalis: Complete Scalp Hair Loss
• 3) By Alopecia Universalis: Total Body Hair Loss
• 4) By Diffuse Alopecia Areata: Generalized Thinning; Scattered Patches
• 5) By Ophiasis Alopecia: Band-like Pattern At The Sides And Back Of The Scalp
• 6) By Other Types: Androgenetic Alopecia; Telogen Effluvium; Traction Alopecia
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Bristol-Myers Squibb Company; Sanofi S.A.; GlaxoSmithKline plc.; Eli Lilly and Co Ltd.; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Bausch Health Companies Inc.; Incyte Corporation; Dr. Reddy's Laboratories Ltd.; Cipla Ltd.; Taisho Pharmaceutical Holdings Co. Ltd.; Lupin Ltd.; Glenmark Pharmaceuticals Ltd.; Almirall S.A.; Torrent Pharmaceuticals Ltd.; Taro Pharmaceutical Industries Ltd.; Aclaris Therapeutics Inc.; BioSplice Therapeutics Inc.; PureTech Health plc; HCell Inc.; Histogen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Alopecia Areata Market Characteristics

3. Alopecia Areata Market Trends And Strategies

4. Alopecia Areata Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Alopecia Areata Growth Analysis And Strategic Analysis Framework

• 5.1. Global Alopecia Areata PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Alopecia Areata Market Growth Rate Analysis
• 5.4. Global Alopecia Areata Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Alopecia Areata Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Alopecia Areata Total Addressable Market (TAM)

6. Alopecia Areata Market Segmentation

• 6.1. Global Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patchy Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis
• Diffuse Alopecia Areata
• Ophiasis Alopecia
• Other Types
• 6.2. Global Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Treatments
• Natural Treatment
• Other Treatments
• 6.3. Global Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trichoscopy
• Skin Biopsy
• Other Diagnoses
• 6.4. Global Alopecia Areata Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Parenteral
• Other Routes Of Administration
• 6.5. Global Alopecia Areata Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.6. Global Alopecia Areata Market, Sub-Segmentation Of Patchy Alopecia Areata, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Patch
• Multiple Patches
• 6.7. Global Alopecia Areata Market, Sub-Segmentation Of Alopecia Totalis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Complete Scalp Hair Loss
• 6.8. Global Alopecia Areata Market, Sub-Segmentation Of Alopecia Universalis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Total Body Hair Loss
• 6.9. Global Alopecia Areata Market, Sub-Segmentation Of Diffuse Alopecia Areata, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Generalized Thinning
• Scattered Patches
• 6.10. Global Alopecia Areata Market, Sub-Segmentation Of Ophiasis Alopecia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Band-like Pattern At The Sides And Back Of The Scalp
• 6.11. Global Alopecia Areata Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Androgenetic Alopecia
• Telogen Effluvium
• Traction Alopecia

7. Alopecia Areata Market Regional And Country Analysis

• 7.1. Global Alopecia Areata Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Alopecia Areata Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Alopecia Areata Market

• 8.1. Asia-Pacific Alopecia Areata Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Alopecia Areata Market

• 9.1. China Alopecia Areata Market Overview
• 9.2. China Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Alopecia Areata Market

• 10.1. India Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Alopecia Areata Market

• 11.1. Japan Alopecia Areata Market Overview
• 11.2. Japan Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Alopecia Areata Market

• 12.1. Australia Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Alopecia Areata Market

• 13.1. Indonesia Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Alopecia Areata Market

• 14.1. South Korea Alopecia Areata Market Overview
• 14.2. South Korea Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Alopecia Areata Market

• 15.1. Western Europe Alopecia Areata Market Overview
• 15.2. Western Europe Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Alopecia Areata Market

• 16.1. UK Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Alopecia Areata Market

• 17.1. Germany Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Alopecia Areata Market

• 18.1. France Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Alopecia Areata Market

• 19.1. Italy Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Alopecia Areata Market

• 20.1. Spain Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Alopecia Areata Market

• 21.1. Eastern Europe Alopecia Areata Market Overview
• 21.2. Eastern Europe Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Alopecia Areata Market

• 22.1. Russia Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Alopecia Areata Market

• 23.1. North America Alopecia Areata Market Overview
• 23.2. North America Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Alopecia Areata Market

• 24.1. USA Alopecia Areata Market Overview
• 24.2. USA Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Alopecia Areata Market

• 25.1. Canada Alopecia Areata Market Overview
• 25.2. Canada Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Alopecia Areata Market

• 26.1. South America Alopecia Areata Market Overview
• 26.2. South America Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Alopecia Areata Market

• 27.1. Brazil Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Alopecia Areata Market

• 28.1. Middle East Alopecia Areata Market Overview
• 28.2. Middle East Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Alopecia Areata Market

• 29.1. Africa Alopecia Areata Market Overview
• 29.2. Africa Alopecia Areata Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Alopecia Areata Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Alopecia Areata Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Alopecia Areata Market Competitive Landscape And Company Profiles

• 30.1. Alopecia Areata Market Competitive Landscape
• 30.2. Alopecia Areata Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Alopecia Areata Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. GlaxoSmithKline plc.
• 31.3. Eli Lilly and Co Ltd.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Sun Pharmaceutical Industries Ltd.
• 31.6. Bausch Health Companies Inc.
• 31.7. Incyte Corporation
• 31.8. Dr. Reddy's Laboratories Ltd.
• 31.9. Cipla Ltd.
• 31.10. Taisho Pharmaceutical Holdings Co. Ltd.
• 31.11. Lupin Ltd.
• 31.12. Glenmark Pharmaceuticals Ltd.
• 31.13. Almirall S.A.
• 31.14. Torrent Pharmaceuticals Ltd.
• 31.15. Taro Pharmaceutical Industries Ltd.

32. Global Alopecia Areata Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alopecia Areata Market

34. Recent Developments In The Alopecia Areata Market

35. Alopecia Areata Market High Potential Countries, Segments and Strategies

• 35.1 Alopecia Areata Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Alopecia Areata Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Alopecia Areata Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer